Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$94.96 /

+0.7 (+0.74%)

, ADPT

Adaptive Biotechnologies

$34.19 /

+0.37 (+1.09%)

04:55
02/23/20
02/23
04:55
02/23/20
04:55

The ASTCT and CIBMTR to hold a joint meeting

American Society for Transplantation & Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) hold the 2020 TCT: Transplantation & Cellular Therapy Meeting will be held in Orlando on February 19-23.

ABBV

AbbVie

$94.96 /

+0.7 (+0.74%)

ADPT

Adaptive Biotechnologies

$34.19 /

+0.37 (+1.09%)

AMGN

Amgen

$222.80 /

+0.62 (+0.28%)

ATNM

Actinium Pharmaceuticals

$0.26 /

+0.0088 (+3.50%)

ATRA

Atara Biotherapeutics

$13.18 /

-0.34 (-2.51%)

AZN

AstraZeneca

$50.17 /

+1.2 (+2.45%)

BLUE

Bluebird Bio

$80.15 /

-2.38 (-2.88%)

CDNA

CareDx

$28.25 /

+0.13 (+0.46%)

CDTX

Cidara Therapeutics

$3.16 /

+ (+0.00%)

CELG

Bought by BMY

$0.00 /

+ (+0.00%)

EQ

Equillium

$5.48 /

+0.38 (+7.45%)

GMDA

Gamida Cell

$4.55 /

-0.2 (-4.21%)

GSK

GlaxoSmithKline

$43.11 /

+0.35 (+0.82%)

HUM

Humana

$369.65 /

-1.9 (-0.51%)

INCY

Incyte

$80.89 /

-1.88 (-2.27%)

JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

KDMN

Kadmon

$5.08 /

+0.03 (+0.59%)

MGTA

Magenta Therapeutics

$14.00 /

-0.02 (-0.14%)

MRK

Merck

$82.34 /

-0.14 (-0.17%)

NVS

Novartis

$96.75 /

+0.44 (+0.46%)

PFE

Pfizer

$35.71 /

-0.13 (-0.36%)

RCKT

Rocket Pharmaceuticals

$22.73 /

-1.01 (-4.25%)

SGEN

Seattle Genetics

$117.00 /

-1.3 (-1.10%)

SNY

Sanofi

$50.83 /

+0.07 (+0.14%)

TAK

Takeda Pharmaceutical

$18.78 /

+0.195 (+1.05%)

  • 24

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 02

    Mar

  • 05

    Mar

  • 06

    Mar

  • 09

    Mar

  • 10

    Mar

  • 13

    Mar

  • 14

    Mar

  • 15

    Mar

  • 17

    Mar

  • 25

    Mar

  • 26

    Mar

  • 04

    Apr

  • 06

    Apr

  • 28

    Apr

  • 26

    May

  • 30

    May

  • 04

    Jun

  • 20

    Aug

ABBV AbbVie
$94.96 /

+0.7 (+0.74%)

02/18/20 Cowen
AbbVie price target raised to $105 from $98 at Cowen
02/14/20 Piper Sandler
Piper says Ubrelvy prescription trajectory bodes well for Biohaven's rimegepant
02/11/20 SunTrust
Allergan price target raised to $202 from $194 at SunTrust
02/10/20 Mizuho
AbbVie price target raised to $104 from $96 at Mizuho
ADPT Adaptive Biotechnologies
$34.19 /

+0.37 (+1.09%)

01/09/20 JPMorgan
Danaher, Thermo named JPMorgan's top 2020 picks in Life Science Tools
11/13/19 JPMorgan
Adaptive Biotechnologies still has upside potential despite rally, says JPMorgan
07/23/19
Fly Intel: Top five analyst initiations
07/23/19 BTIG
Adaptive Biotechnologies initiated with a Buy at BTIG
AMGN Amgen
$222.80 /

+0.62 (+0.28%)

02/14/20
Vertex remains top large-cap biotech pick at Citi
02/06/20 Argus
Amgen trading at attractive valuation, says Argus
02/03/20 SunTrust
Amgen price target lowered to $254 from $265 at SunTrust
01/31/20
Fly Intel: Top five analyst downgrades
ATNM Actinium Pharmaceuticals
$0.26 /

+0.0088 (+3.50%)

08/08/19 William Blair
Actinium Pharmaceuticals initiated with an Outperform at William Blair
ATRA Atara Biotherapeutics
$13.18 /

-0.34 (-2.51%)

11/08/19 JPMorgan
Atara Biotherapeutics downgraded to on lack of catalysts at JPMorgan
11/08/19 JPMorgan
Atara Biotherapeutics downgraded to Neutral from Overweight at JPMorgan
10/25/19 Stifel
Stifel recommend buying into weakness on Atara Biotherapeutics CSO resignation
10/25/19 Mizuho
Mizuho says CSO Chris Haqq to remain on as Atara adviser
AZN AstraZeneca
$50.17 /

+1.2 (+2.45%)

01/27/20 William Blair
PhaseBio could see increase to PB2452 addressable market, says William Blair
01/22/20 Liberum
Sanofi downgraded to Hold from Buy at Liberum (earlier)
01/22/20 Oppenheimer
Amarin price target raised to $13 from $8 at Oppenheimer
01/13/20 Roth Capital
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
BLUE Bluebird Bio
$80.15 /

-2.38 (-2.88%)

02/20/20 Oppenheimer
Bluebird Bio price target lowered to $128 from $135 at Oppenheimer
02/19/20 Raymond James
Bluebird Bio downgraded to Market Perform from Strong Buy at Raymond James
02/19/20 Piper Sandler
Bluebird pushed Biologics License Application to second half, says Piper Sandler
02/03/20 Evercore ISI
Bluebird Bio upgraded to Outperform on undervalued assets at Evercore ISI
CDNA CareDx
$28.25 /

+0.13 (+0.46%)

01/27/20 Piper Sandler
CareDx gained first private payer decision for AlloSure, says Piper Sandler
12/19/19 Craig-Hallum
Natera kidney test to be covered under Medicare in February, says Craig-Hallum
12/19/19 Piper Sandler
CareDx should be bought on weakness from Natera coverage, says Piper
11/01/19 Piper Sandler
CareDx continues to build 'moat around transplant,' says Piper Jaffray
CDTX Cidara Therapeutics
$3.16 /

+ (+0.00%)

01/27/20 Cantor Fitzgerald
Street underappreciates Cidara's Cloudbreak AVCs, says Cantor Fitzgerald
12/04/19 WBB Securities
Cidara Therapeutics upgraded to Buy from Speculative Buy at WBB Securities
09/04/19 BTIG
Cidara Therapeutics price target lowered to $7 from $20 at BTIG
09/04/19
Cidara Therapeutics upgraded to Outperform after partnership at Wedbush
CELG Bought by BMY
$0.00 /

+ (+0.00%)

11/01/19 Standpoint Research
Celgene downgraded to Hold from Buy at Standpoint Research
11/01/19 Baird
Celgene downgraded to Neutral at Baird
11/01/19 Baird
Celgene downgraded d to Neutral from Outperform at Baird
09/23/19 Guggenheim
Agios Pharmaceuticals upgraded to Buy following selloff at Guggenheim
EQ Equillium
$5.48 /

+0.38 (+7.45%)

01/03/20 Stifel
Stifel says Incyte setback means Equillium may have most advanced aGVHD product
07/02/19 H.C. Wainwright
Equillium initiated with a Buy at H.C. Wainwright
GMDA Gamida Cell
$4.55 /

-0.2 (-4.21%)

09/20/19 JMP Securities
Gamida Cell initiated with an Outperform at JMP Securities
GSK GlaxoSmithKline
$43.11 /

+0.35 (+0.82%)

01/16/20 Barclays
GlaxoSmithKline downgraded to Underweight from Equal Weight at Barclays
12/16/19 Goldman Sachs
BioMarin, Regeneron among Goldman's six Healthcare 'laggards' for 2020
12/03/19 Morgan Stanley
Morgan Stanley sees high odds of Bluebird trading up after multiple myeloma data
12/02/19 SVB Leerink
GlaxoSmithKline initiated with an Outperform at SVB Leerink
HUM Humana
$369.65 /

-1.9 (-0.51%)

02/20/20 Stephens
Stephens watching near-term MCO stock reactions after Bloomberg's 'rough' debate
02/18/20 Deutsche Bank
Deutsche raises price targets in Managed Care on fading political risks
01/23/20 UBS
Humana price target raised to $406 from $321 at UBS
01/08/20 Credit Suisse
Humana price target raised to $400 from $378 at Credit Suisse
INCY Incyte
$80.89 /

-1.88 (-2.27%)

02/19/20 Piper Sandler
Incyte data on topical ruxolitinib 'impressive,' says Piper Sandler
02/19/20 Nomura Instinet
Incyte price target raised to $116 from $111 at Nomura Instinet
02/13/20 Piper Sandler
Piper Sandler says Incyte's Jakafi, 2020 launches are 'underappreciated'
02/04/20 BofA
Incyte reinstated with a Neutral at BofA
JAZ Jazz Technologies
$0.00 /

+ (+0.00%)

KDMN Kadmon
$5.08 /

+0.03 (+0.59%)

01/10/20 Nomura Instinet
Kadmon initiated with a Buy at Nomura Instinet
01/03/20 Cantor Fitzgerald
Incyte setback supports GVHD opportunity for Kadmon, says Cantor Fitzgerald
11/12/19 Cantor Fitzgerald
Kadmon price target raised to $10 from $8 at Cantor Fitzgerald
09/06/19 Cantor Fitzgerald
Cantor starts 'under-the-radar' Kadmon with Overweight rating
MGTA Magenta Therapeutics
$14.00 /

-0.02 (-0.14%)

01/15/20 BTIG
BTIG sees 'no real reason' for Magenta Therapeutics sell-off
12/06/19 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
12/06/19 Goldman Sachs
Magenta Therapeutics assumed with a Neutral at Goldman Sachs
03/25/19 Goldman Sachs
Magenta Therapeutics downgraded to Neutral on valuation at Goldman Sachs
MRK Merck
$82.34 /

-0.14 (-0.17%)

02/19/20 Spin-Off Research
Merck initiated with a Buy at Spin-Off Research
02/14/20 SunTrust
Pfenex initiated with a Buy at SunTrust
02/06/20 RBC Capital
Merck price target lowered to $92 from $99 at RBC Capital
02/06/20 Maxim
Armata Pharmaceuticals initiated with a Buy at Maxim
NVS Novartis
$96.75 /

+0.44 (+0.46%)

02/17/20 Citi
Novartis downgraded to Neutral from Buy at Citi
02/03/20 Oppenheimer
Eyenovia downgraded to Perform from Outperform at Oppenheimer
01/06/20 JPMorgan
JPMorgan upgrades Sanofi to Overweight on 'unjustified' valuation gap
PFE Pfizer
$35.71 /

-0.13 (-0.36%)

02/12/20 Baird
Exact Sciences weakness would be buying opportunity, says Baird
02/11/20 Roth Capital
GlycoMimetics termination notice from Pfizer no surprise, says Roth Capital
02/06/20 Mizuho
Pfizer initiated with a Buy, $42 price target at Mizuho
02/05/20 Mizuho
Pfizer initiated with a Buy at Mizuho
RCKT Rocket Pharmaceuticals
$22.73 /

-1.01 (-4.25%)

12/09/19 Oppenheimer
Rocket Pharmaceuticals price target raised to $42 from $36 at Oppenheimer
12/06/19 Baird
Rocket Pharmaceuticals elevated to Fresh Pick, target raised to $41 at Baird
11/18/19 Piper Sandler
Rocket may be next leading lentiviral vector company, says Piper Jaffray
11/07/19 Piper Sandler
Rocket Pharmaceuticals data by year-end to boost shares, says Piper Jaffray
SGEN Seattle Genetics
$117.00 /

-1.3 (-1.10%)

02/18/20 Barclays
Seattle Genetics downgraded to Equal Weight from Overweight at Barclays
02/18/20 Barclays
Seattle Genetics downgraded to Equal Weight from Overweight at Barclays
02/12/20 H.C. Wainwright
Seattle Genetics price target raised to $150 from $140 at H.C. Wainwright
02/11/20 Goldman Sachs
Goldman boosts Seattle Genetics target to $165, sees attractive setup
SNY Sanofi
$50.83 /

+0.07 (+0.14%)

02/11/20
Fly Intel: Top five analyst initiations
02/11/20 SVB Leerink
Sanofi initiated with a Market Perform at SVB Leerink
02/06/20 H.C. Wainwright
Principia Biopharma price target raised to $70 from $62 at H.C. Wainwright
01/26/20 Goldman Sachs
Denali Therapeutics upgraded to Buy from Neutral at Goldman Sachs
TAK Takeda Pharmaceutical
$18.78 /

+0.195 (+1.05%)

02/12/20 Wells Fargo
Fate Therapeutics price target raised to $34 from $24 at Wells Fargo
11/19/19 Needham
Phathom Pharmaceuticals initiated with a Buy at Needham
11/01/19 Cowen
Takeda Pharmaceutical initiated with a Market Perform at Cowen
09/24/19 Jefferies
Takeda Pharmaceutical initiated with a Buy at Jefferies

TODAY'S FREE FLY STORIES

Hot Stocks
Intuit launches free Stimulus Registration product » 14:02
04/05/20
04/05
14:02
04/05/20
14:02
INTU

Intuit

$218.12 /

-7.19 (-3.19%)

TurboTax launched a free,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Great Ajax announces $80M private placement » 13:57
04/05/20
04/05
13:57
04/05/20
13:57
AJX

Great Ajax

$4.47 /

+0.06 (+1.36%)

Great Ajax announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
MGM Resorts participates in a conference call with JPMorgan » 13:51
04/05/20
04/05
13:51
04/05/20
13:51
MGM

MGM Resorts

$10.57 /

-0.94 (-8.17%)

Gaming & Lodging…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
United Therapeutics participates in a conference with JPMorgan » 13:44
04/05/20
04/05
13:44
04/05/20
13:44
UTHR

United Therapeutics

$92.58 /

-0.83 (-0.89%)

Biotechnology Analyst Fye…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
JPMorgan LatAm utilities analysts to hold an analyst/industry conference call » 13:37
04/05/20
04/05
13:37
04/05/20
13:37

LatAm Utilities Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
JPMorgan retail analysts to hold an analyst/industry conference call » 13:33
04/05/20
04/05
13:33
04/05/20
13:33

Retail/Hardlines &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
JPMorgan financial analyst to hold an analyst/industry conference call » 13:28
04/05/20
04/05
13:28
04/05/20
13:28

Financial Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
JPMorgan LatAm economist to hold an analyst/industry conference call » 13:26
04/05/20
04/05
13:26
04/05/20
13:26

LatAm Economist Pereira…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Red Lion Hotels to host conference call » 12:52
04/05/20
04/05
12:52
04/05/20
12:52
RLH

Red Lion Hotels

$1.27 /

+0.005 (+0.40%)

Management discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Itau Unibanco to hold a conference call » 12:43
04/05/20
04/05
12:43
04/05/20
12:43
ITUB

Itau Unibanco

$3.90 /

-0.2 (-4.88%)

President & CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Floor & Decor price target lowered to $30 from $55 at Stifel » 11:49
04/05/20
04/05
11:49
04/05/20
11:49
FND

Floor & Decor

$27.03 /

-1.43 (-5.02%)

Stifel analyst John Baugh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Applied Therapeutics participates in a conference call with Baird » 16:50
04/04/20
04/04
16:50
04/04/20
16:50
APLT

Applied Therapeutics

$31.86 /

+0.8 (+2.58%)

Conference call with…

Conference call with management will be held on April 7 at 1:30 pm hosted by Baird.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Aveo Pharmaceuticals participates in a conference call with Baird » 16:46
04/04/20
04/04
16:46
04/04/20
16:46
AVEO

Aveo Pharmaceuticals

$3.45 /

-0.22 (-5.99%)

Conference call with…

Conference call with management will be held on April 14 at 1:30 pm hosted by Baird.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Esperion participates in a conference call with Credit Suisse » 16:13
04/04/20
04/04
16:13
04/04/20
16:13
ESPR

Esperion

$30.93 /

-2.13 (-6.44%)

Conference call with…

Conference call with management will be held on April 9 at 11 am hosted by Credit Suisse.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Credit Suisse financial service analyst to hold analyst/industry conference call » 16:10
04/04/20
04/04
16:10
04/04/20
16:10

Financial Services…

Financial Services Analysts provide an Industry update and outlook on an Analyst/Industry conference call to be held on April 8 at 10 am.

Conference/Events
Credit Suisse aero/defense analysts to hold an analyst/industry conference call » 16:07
04/04/20
04/04
16:07
04/04/20
16:07

Aerospace & Defense…

Aerospace & Defense Analysts discuss the aviation crisis with an aviation expert, Matt Pfeifer, on an Analyst/Industry conference call to be held on April 6 at 10:30 am.

Conference/Events
Credit Suisse auto/auto service analyst to hold analyst/industry conference call » 16:05
04/04/20
04/04
16:05
04/04/20
16:05

Automotive/Automotive…

Automotive/Automotive Services Analysts, along with Stephen Brown of Fitch Ratings, discuss auto credit and liquidity considerations on an Analyst/Industry conference call to be held on April 7 at 1 pm.

Conference/Events
Lowe's participates in a conference call with Credit Suisse » 14:18
04/04/20
04/04
14:18
04/04/20
14:18
LOW

Lowe's

$82.04 /

-0.97 (-1.17%)

Consumer Services Analyst…

Consumer Services Analyst Sigman holds a conference call with President & CEO Ellison and CFO Denton on April 8 at 4 pm hosted by Credit Suisse. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Immunomedics to host conference call » 14:11
04/04/20
04/04
14:11
04/04/20
14:11
IMMU

Immunomedics

$9.39 /

-1.25 (-11.75%)

Management to provide a…

Management to provide a clinical development and general corporate update on a conference call to be held on April 6 at 8 am. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Roth Capital biotech analysts to hold an analyst/industry conference call » 11:15
04/04/20
04/04
11:15
04/04/20
11:15

Biotech Analysts, along…

Biotech Analysts, along with Dr. Juan Frias, discuss Non-Alcoholic SteatoHepatitis (NASH) on an Analyst/Industry conference call to be held on April 3 at 12 pm.

Periodicals
Battle between Mack-Call, activist investor only heating up, Barron's says » 10:13
04/04/20
04/04
10:13
04/04/20
10:13
CLI

Mack-Cali Realty

$13.86 /

-0.41 (-2.87%)

The coronavirus pandemic…

The coronavirus pandemic has put some proxy battles on ice, but the duel between real-estate investment trust Mack-Cali Realty and activist investor Bow Street is only heating up, Carleton English writes in this week's edition of Barron's. Mack-Cali has announced that it doesn't plan to renominate four Bow Street-nominated directors. The REIT claimed the four, who joined after a proxy contest with Bow Street last year, "sought to advance Bow Street's self-interested agenda," which it claims includes a "fire sale" of the company's properties, which Bow Street denies. English does not see this fight winding down soon. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
J&J, Chevron among names with safe dividends for now, Barron's says » 10:04
04/04/20
04/04
10:04
04/04/20
10:04
TROW

T. Rowe Price

$95.02 /

-2.13 (-2.19%)

, PG

Procter & Gamble

$115.10 /

+0.68 (+0.59%)

, MDT

Medtronic

$86.17 /

+0.02 (+0.02%)

, KMB

Kimberly-Clark

$130.02 /

+0.58 (+0.45%)

, JNJ

Johnson & Johnson

$134.13 /

+1.05 (+0.79%)

, HRL

Hormel Foods

$48.37 /

+0.72 (+1.51%)

, CVX

Chevron

$75.15 /

-1.07 (-1.40%)

, ABT

Abbott

$79.50 /

+0.075 (+0.09%)

Among the 64 S&P 500…

Among the 64 S&P 500 Dividend Aristocrats, the dividends of Abbott Laboratories (ABT), Chevron (CVX), Hormel Foods (HRL), Johnson & Johnson (JNJ), Kimberly-Clark (KMB), Medtronic (MDT), Procter & Gamble (PG), and T. Rowe Price (TROW) look safe for now, thanks in part to relatively low debt loads, Lawrence Strauss writes in this week's editions of Barron's. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Internet doing just fine during pandemic, Barron's says » 09:52
04/04/20
04/04
09:52
04/04/20
09:52
VZ

Verizon

$54.72 /

-0.52 (-0.94%)

, T

AT&T

$27.46 /

-1.305 (-4.54%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

, CMCSA

Comcast

$33.94 /

-0.43 (-1.25%)

, NFLX

Netflix

$361.76 /

-8.37 (-2.26%)

, AMZN

Amazon.com

$1,905.33 /

-11.69 (-0.61%)

, AAPL

Apple

$241.43 /

-3.27 (-1.34%)

With everyone stuck…

With everyone stuck working and studying from home, Americans have become sensitive to any news about internet slowdowns, Eric Savitz writes in this week's edition of Barron's. Last month, European Union Commissioner Thierry Breton tweeted that everyone should all stream video in lower-quality standard definition in order to "secure Internet access for all." In response, Apple (AAPL), Amazon.com (AMZN), Netflix (NFLX), and Google's YouTube all announced plans to reduce their video streaming quality in Europe, the author notes. The good news is that U.S. networks are handling the traffic spikes without any major hiccups, with Comcast (CMCSA), the largest U.S. internet service provider, saying that its network is working well, with tests done 700,000 times a day through customer modems showing average speeds running 110% to 115% of contracted rates. AT&T (T), the No. 2 U.S. internet service provider, likewise asserts that its network is performing "very well" during the pandemic, Savitz adds, while Verizon (VZ) also saying its network is handling the traffic well. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Google, Facebook can't save advertising industry this time, Barron's says » 09:21
04/04/20
04/04
09:21
04/04/20
09:21
GOOGL

Alphabet Class A

$1,092.51 /

-24.78 (-2.22%)

, GOOG

Alphabet

$1,097.93 /

-25.87 (-2.30%)

, TWTR

Twitter

$23.08 /

+0.07 (+0.30%)

, FB

Facebook

$154.19 /

-3.92 (-2.48%)

Across the media…

Across the media landscape, advertising is disappearing, one more casualty of the global economic shutdown, and new technology won't be a savior as this is an equal-opportunity problem across print, TV, digital, radio, and outdoor advertising, Eric Savitz writes in this week's edition of Barron's. Even the most prominent ad buyers lack reasons, and often the means, to buy ads, the author notes, while many of the small and medium-size businesses that buy online ads are struggling to stay solvent. Both Facebook (FB) and Twitter (TWTR) have already warned that they will take a hit from the downturn, and Alphabet's Google (GOOGL) no doubt is seeing the same effects, but so far hasn't discussed the matter, the publication adds. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Week in Review: How Trump's policies moved stocks » 07:29
04/04/20
04/04
07:29
04/04/20
07:29
XOM

Exxon Mobil

$39.20 /

-1.19 (-2.95%)

, CVX

Chevron

$75.15 /

-1.07 (-1.40%)

, NBL

Noble Energy

$6.17 /

-0.12 (-1.91%)

, XEC

Cimarex Energy

$16.85 /

+0.4 (+2.43%)

, FANG

Diamondback Energy

$31.58 /

+2.53 (+8.71%)

, RDS.A

Royal Dutch Shell

$36.24 /

-2.78 (-7.12%)

, RDS.B

Royal Dutch Shell

$34.42 /

-2.36 (-6.42%)

, DVN

Devon Energy

$8.38 /

+0.59 (+7.57%)

, BP

BP

$24.72 /

-1.32 (-5.07%)

, COP

ConocoPhillips

$32.90 /

-0.945 (-2.79%)

, MRO

Marathon Oil

$3.65 /

+0.195 (+5.65%)

, BAC

Bank of America

$20.03 /

-0.535 (-2.60%)

, WFC

Wells Fargo

$26.23 /

-0.98 (-3.60%)

, C

Citi

$37.48 /

-1.82 (-4.63%)

, JPM

JPMorgan

$84.08 /

-1.57 (-1.83%)

, MMM

3M

$133.90 /

-3.96 (-2.87%)

, VMC

Vulcan Materials

$99.66 /

-7.52 (-7.02%)

, EXP

Eagle Materials

$49.80 /

-4.32 (-7.98%)

, GVA

Granite Construction

$14.13 /

-1.4 (-9.01%)

, NUE

Nucor

$35.63 /

-0.38 (-1.06%)

, PWR

Quanta Services

$30.56 /

-0.07 (-0.23%)

, J

Jacobs

$78.99 /

-2.26 (-2.78%)

, MLM

Martin Marietta

$169.65 /

-11.07 (-6.13%)

, DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

, FCAU

Fiat Chrysler

$6.73 /

-0.07 (-1.03%)

, F

Ford

$4.24 /

-0.105 (-2.42%)

, GM

General Motors

$18.03 /

-0.15 (-0.83%)

, HMC

Honda

$19.85 /

-1.05 (-5.02%)

, NSANY

Nissan

$0.00 /

+ (+0.00%)

, TSLA

Tesla

$479.71 /

+25.715 (+5.66%)

, TM

Toyota

$115.08 /

-2.71 (-2.30%)

, VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.